Vertex: New, Longer-Term Casgevy Data Makes Case For Blockbuster Sales Seeking Alpha Vertex (VRTX) 2 weeks
Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030 The Motley Fool 22 hours
Google to shore up Vertex AI’s enterprise credentials with addition of Mistral Small, Large and Codestral models VentureBeat 2 days
Vertex Pharmaceutical Incorporated. (VRTX): Analysts are Bullish on this Healthcare Stock’s Strong Financial Performance in Q1 Insider Monkey 5 days
Vertex Pharmaceuticals Incorporated (VRTX): A Promising Feminist Stock To Buy? Insider Monkey 2 weeks
Vertex Pharmaceuticals (VRTX) Stock Declines While Market Improves: Some Information for Investors Zacks 2 weeks
Vertex Pharmaceuticals Incorporated (VRTX) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript) Seeking Alpha 2 weeks
Vertex Pharmaceuticals Incorporated (VRTX) The 44th Annual William Blair Growth Stock Conference Seeking Alpha 3 weeks
Is Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) the Leading Gene Therapy Stock to Buy Now? Insider Monkey 4 weeks
Vertex Stock Recently Hit All-Time High, Leads 8 Top Performers New To IBD Stock Lists Investor's Business Daily 4 weeks
Vertex Pharmaceuticals Is Racing Towards a New Blockbuster: Why the Stock Is a Smart Buy The Motley Fool 2 months
Vertex’s Pain Drug Could Be Worth Up To $11.4 Billion — Ongoing Debate Sparks Shares Investor's Business Daily 2 months
Biotech Stock Roundup: BIIB, BMY’s Q1 Earnings, INCY’s Acquisition & Updates from VRTX Zacks 2 months
If You’d Invested $10,000 in Vertex Pharmaceuticals 5 Years Ago, Here’s How Much You’d Have Today The Motley Fool 2 months
Vertex Pharmaceuticals (VRTX) Stock Falls Amid Market Uptick: What Investors Need to Know Zacks 2 months
What Vertex Pharmaceuticals Is Getting With Acquisition Of Alpine Immune Sciences Seeking Alpha 3 months
Vertex Pharma bets on kidney disease treatment with $4.9 billion Alpine Immune deal Investing.com 3 months